Research Insights
Insights are moderated by the Research Hub team and offer an at-a-glance overview of interesting research findings.
The Chinese medicine formulas Zuo Gui Wan and You Gui Wan have the potential to treat premature ovarian failure through different pharmacological pathways.
Network Pharmacology Premature ovarian failure (POF) You Gui Wan
This study used a public database to identify the active ingredients and potential targets of the Zuo Gui Wan and You Gui Wan compounds. These were analyzed in relation to premature ovarian failure (POF) related genes obtained from OMIM and GeneCards. A protein-protein interaction network was established using STRING, and a drug-active ingredient-target gene network was constructed. The study thus identified similarities and differences in potential targets, active ingredients, and enriched pathways between the two compounds.
Analyzing the drug-target-pathway network revealed that both compounds contain multiple common active ingredients, as well as unique components, and share several targets in the treatment of POF, showing similar core mechanisms of action. However, each compound also targets some unique pathways, which indicates their differential approaches to POF treatment.
View Article
In a meta-analysis of 14 trials with 1030 women, acupoint stimulation and Chinese Herbal Medicine were effective in improving menstrual cycles, perimenopausal symptoms, and sex hormone levels in comparison to Hormone Replacement Therapy.
Systematic Review Chinese Herbal Medicine
In a meta-analysis involving 14 trials with 1030 women experiencing Premature Ovarian Insufficiency (POI), acupoint stimulation and Chinese Herbal Medicine (CHM) were found to offer benefits in normalizing menstrual cycles and improving perimenopausal symptoms, compared to Hormone Replacement Therapy (HRT). These treatments also effectively lowered follicle stimulating hormone levels and increased estradiol levels when compared to HRT. However, there were no significant differences in luteinizing hormone levels or adverse effects between the groups. The conclusion of the study is that acupoint stimulation and CHM can be considered complementary therapies for alleviating menstrual disorders, perimenopausal symptoms, and serum sex hormone levels in POI females.
View Article
The present study indicated that acupuncture had an advantage over hormone replacement therapy in reducing serum FSH level and increasing serum E2 level in women with premature ovarian insufficiency.
Systematic Review FSH HRT Ovarian Function
Eight eligible RCTs with a total of 496 POI patients were included in the meta-analysis. The pooled results showed that there was a significant reduction in the basal serum FSH level and a remarkable elevation in the basal E2 level in the acupuncture group when compared with the control. Subgroup analysis showed that compared with HRT, a significant decrease in the FSH level was observed in both acupuncture alone and acupuncture plus HRT, while a remarkable elevation of E2 was only found in acupuncture plus HRT. There was no significant difference in the LH level between acupuncture and HRT, only one trial reported AMH, and no significant difference was found between acupuncture and HRT.
View Article
Acupuncture may impact Luteinized Unruptured Follicle Syndrome (LUFS) by lowering FSH, increasing E2, and resuming menstruation.
Systematic Review
This systematic review and meta-analysis assessed the potential of acupuncture for treating Luteinized Unruptured Follicle Syndrome (LUFS) through Randomized Controlled Trials (RCTs). Analyzing 8 studies involving 620 participants, the review found that acupuncture, whether alone or combined with drugs, could lower follicle-stimulating hormone (FSH) levels and increase the likelihood of menstruation resumption. Serum estradiol (E2) levels significantly increased with acupuncture, while luteinizing hormone (LH) levels showed no clear changes. Limited data on adverse events (AEs) suggested acupuncture's relative safety. However, due to small sample sizes, risk of bias, and varying study methodologies, the overall evidence quality was rated as "low" or "very low." This suggests a potential benefit of acupuncture for LUFS, but further high-quality studies are necessary to establish its effectiveness and safety definitively.
View Article
Clinical Trials
Clinical trials are research studies that involve people and are conducted to evaluate the safety and efficacy of new treatments or interventions, such as drugs, medical devices, or behavioural therapies.
Study Protocols
Published study protocols are detailed plans that outline the objectives, methodology, statistical analyses, and organisation of a research study that have been made publicly available for others to review and use as a reference.
Presentation Slides
Chinese Medicine Research Hub
Network Pharmacology
The Chinese medicine formulas Zuo Gui Wan and You Gui Wan have the potential to treat premature ovarian failure through different pharmacological pathways.
2022 Combinatorial Chemistry & High Throughput Screening A Network Pharmacology Study on the Similarities and Differences in the Mechanisms of Zuo Gui Wan/You Gui Wan for the Treatment of Premature Ovarian Failure
Shanshan Mei, Chaoqin Yu, Jie Ding, Wen Cheng
Chinese Medicine Research Hub
Systematic Review
In a meta-analysis of 14 trials with 1030 women, acupoint stimulation and Chinese Herbal Medicine were effective in improving menstrual cycles, perimenopausal symptoms, and sex hormone levels in comparison to Hormone Replacement Therapy.
2020 Complementary Therapies in Medicine Acupoint stimulation and Chinese herbal medicines for the treatment of premature ovarian insufficiency: A systematic review and meta-analysis
Li Y, Xia G, Tan Y, Shuai J
Chinese Medicine Research Hub
Systematic Review
The present study indicated that acupuncture had an advantage over hormone replacement therapy in reducing serum FSH level and increasing serum E2 level in women with premature ovarian insufficiency.
2020 Journal of Acupuncture and Tuina Science Acupuncture for premature ovarian insufficiency: a systematic review and meta-analysis
Yin, Yq., Xu, Hf., Fang, Yg. et al.
Chinese Medicine Research Hub
Systematic Review
Acupuncture may impact Luteinized Unruptured Follicle Syndrome (LUFS) by lowering FSH, increasing E2, and resuming menstruation.
2015 Evidence-Based Complementary and Alternative Medicine Effectiveness of Acupuncture for Primary Ovarian Insufficiency: A Systematic Review and Meta-Analysis
Jo J, Lee YJ, Lee H
Executive Summary
Write an executive summary in the form of a blog article on the topic of "Research into Chinese medicine treatment for Ovarian Insufficiency" summarising the research below and using language that can be easily understood by patients and avoiding medical jargon using a professional and caring tone of voice.
Write an executive summary in the form of a blog article on the topic of "Researched Chinese medicine treatments for Ovarian Insufficiency" summarising the research below in an objective and easy to understand way, and using language that can be easily understood by patients. Group the article into Chinese medicine treatments first, followed by nutrition and other treatments. Avoid using medical jargon and use a professional and caring tone of voice.
Write me a concise but easy to understand executive summary on the topic of "Chinese medicine treatments for Ovarian Insufficiency" based on the following research that I will give you. Your summary should be 2 paragraphs long in Australian English spelling and include references to the studies.
A Network Pharmacology published in 2022 in the journal Combinatorial Chemistry & High Throughput Screening found that The Chinese medicine formulas Zuo Gui Wan and You Gui Wan have the potential to treat premature ovarian failure through different pharmacological pathways. This study used a public database to identify the active ingredients and potential targets of the Zuo Gui Wan and You Gui Wan compounds. These were analyzed in relation to premature ovarian failure (POF) related genes obtained from OMIM and GeneCards. A protein-protein interaction network was established using STRING, and a drug-active ingredient-target gene network was constructed. The study thus identified similarities and differences in potential targets, active ingredients, and enriched pathways between the two compounds.
Analyzing the drug-target-pathway network revealed that both compounds contain multiple common active ingredients, as well as unique components, and share several targets in the treatment of POF, showing similar core mechanisms of action. However, each compound also targets some unique pathways, which indicates their differential approaches to POF treatment.
A Systematic Review published in 2020 in the journal Complementary Therapies in Medicine found that In a meta-analysis of 14 trials with 1030 women, acupoint stimulation and Chinese Herbal Medicine were effective in improving menstrual cycles, perimenopausal symptoms, and sex hormone levels in comparison to Hormone Replacement Therapy. In a meta-analysis involving 14 trials with 1030 women experiencing Premature Ovarian Insufficiency (POI), acupoint stimulation and Chinese Herbal Medicine (CHM) were found to offer benefits in normalizing menstrual cycles and improving perimenopausal symptoms, compared to Hormone Replacement Therapy (HRT). These treatments also effectively lowered follicle stimulating hormone levels and increased estradiol levels when compared to HRT. However, there were no significant differences in luteinizing hormone levels or adverse effects between the groups. The conclusion of the study is that acupoint stimulation and CHM can be considered complementary therapies for alleviating menstrual disorders, perimenopausal symptoms, and serum sex hormone levels in POI females.
A Systematic Review published in 2020 in the journal Journal of Acupuncture and Tuina Science found that The present study indicated that acupuncture had an advantage over hormone replacement therapy in reducing serum FSH level and increasing serum E2 level in women with premature ovarian insufficiency. Eight eligible RCTs with a total of 496 POI patients were included in the meta-analysis. The pooled results showed that there was a significant reduction in the basal serum FSH level and a remarkable elevation in the basal E2 level in the acupuncture group when compared with the control. Subgroup analysis showed that compared with HRT, a significant decrease in the FSH level was observed in both acupuncture alone and acupuncture plus HRT, while a remarkable elevation of E2 was only found in acupuncture plus HRT. There was no significant difference in the LH level between acupuncture and HRT, only one trial reported AMH, and no significant difference was found between acupuncture and HRT.
A Systematic Review published in 2015 in the journal Evidence-Based Complementary and Alternative Medicine found that Acupuncture may impact Luteinized Unruptured Follicle Syndrome (LUFS) by lowering FSH, increasing E2, and resuming menstruation. This systematic review and meta-analysis assessed the potential of acupuncture for treating Luteinized Unruptured Follicle Syndrome (LUFS) through Randomized Controlled Trials (RCTs). Analyzing 8 studies involving 620 participants, the review found that acupuncture, whether alone or combined with drugs, could lower follicle-stimulating hormone (FSH) levels and increase the likelihood of menstruation resumption. Serum estradiol (E2) levels significantly increased with acupuncture, while luteinizing hormone (LH) levels showed no clear changes. Limited data on adverse events (AEs) suggested acupuncture's relative safety. However, due to small sample sizes, risk of bias, and varying study methodologies, the overall evidence quality was rated as "low" or "very low." This suggests a potential benefit of acupuncture for LUFS, but further high-quality studies are necessary to establish its effectiveness and safety definitively.